A Study to Assess the Safety, Tolerability and Preliminary Efficacy of ASP0367 (MA-0211) in Pediatric Male Participants With Duchenne Muscular Dystrophy (DMD)

NCT04184882 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

8

Enrollment

INDUSTRY

Sponsor class

Stopped Operational Reasons

Conditions

Duchenne Muscular Dystrophy (DMD)

Interventions

DRUG: Bocidelpar
DRUG: Placebo

Sponsor

Astellas Pharma Inc